Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pathological choice: the neuroscience of gambling and gambling addiction.
Clark L, Averbeck B, Payer D, Sescousse G, Winstanley CA, Xue G. Clark L, et al. Among authors: Payer D. J Neurosci. 2013 Nov 6;33(45):17617-23. doi: 10.1523/JNEUROSCI.3231-13.2013. J Neurosci. 2013. PMID: 24198353 Free PMC article. Review.
Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study.
Boileau I, Payer D, Houle S, Behzadi A, Rusjan PM, Tong J, Wilkins D, Selby P, George TP, Zack M, Furukawa Y, McCluskey T, Wilson AA, Kish SJ. Boileau I, et al. Among authors: Payer D. Version 2. J Neurosci. 2012 Jan 25;32(4):1353-9. doi: 10.1523/JNEUROSCI.4371-11.2012. J Neurosci. 2012. PMID: 22279219 Free PMC article.
The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride.
Boileau I, Payer D, Chugani B, Lobo D, Behzadi A, Rusjan PM, Houle S, Wilson AA, Warsh J, Kish SJ, Zack M. Boileau I, et al. Among authors: Payer D. Addiction. 2013 May;108(5):953-63. doi: 10.1111/add.12066. Epub 2013 Jan 3. Addiction. 2013. PMID: 23167711
MEASUREMENTS: Two PET scans (one with the D3 receptor preferring agonist [11C]-(+)-propyl-hexahydro-naphtho-oxazin (PHNO) and the other with [11C]raclopride) to assess D(2/3) DA receptor availability, and behavioural measures (self-report questionnaires and slot-machine game) to assess subjective effects and relationships to PET measures. ...
MEASUREMENTS: Two PET scans (one with the D3 receptor preferring agonist [11C]-(+)-propyl-hexahydro-naphtho-oxazin (PHNO) and the other with …
Corticotropin-releasing hormone and dopamine release in healthy individuals.
Payer D, Williams B, Mansouri E, Stevanovski S, Nakajima S, Le Foll B, Kish S, Houle S, Mizrahi R, George SR, George TP, Boileau I. Payer D, et al. Psychoneuroendocrinology. 2017 Feb;76:192-196. doi: 10.1016/j.psyneuen.2016.11.034. Epub 2016 Dec 1. Psychoneuroendocrinology. 2017. PMID: 27951520
Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans.
Le Foll B, Payer D, Di Ciano P, Guranda M, Nakajima S, Tong J, Mansouri E, Wilson AA, Houle S, Meyer JH, Graff-Guerrero A, Boileau I. Le Foll B, et al. Among authors: Payer D. Neuropsychopharmacology. 2016 Jan;41(2):529-37. doi: 10.1038/npp.2015.177. Epub 2015 Jun 19. Neuropsychopharmacology. 2016. PMID: 26089182 Free PMC article.
34 results
Jump to page
Feedback